15 Stocks Moving in Tuesday's Pre-Market Session

Gainers Neovasc Inc (NASDAQ: NVCN) shares rose 77.7% to $7.02 in pre-market trading after the company reported submission of Premarket Approval application for its Neovasc Reducer.

Benzinga · 12/31/2019 12:32

Gainers

  • Neovasc Inc (NASDAQ: NVCN) shares rose 77.7% to $7.02 in pre-market trading after the company reported submission of Premarket Approval application for its Neovasc Reducer.
  • Seadrill Limited (NYSE: SDRL) shares rose 23.3% to $2.91 in pre-market trading after the company reported a 3-year contract for each of the AOD II and AOD III. The contract value is expected to be $98 million and $101 million respectively.
  • Savara Inc. (NASDAQ: SVRA) shares rose 22.2% to $6.00 in pre-market trading after climbing 183.82% on Monday. Bain Capital Life Sciences Fund reported a 9.99% active stake in the company.
  • NIO Limited (NYSE: NIO) rose 12% to $4.21 in pre-market trading after surging 53.72% on Monday.
  • Urovant Sciences Ltd (NASDAQ: UROV) rose 10.7% to $14.50 in pre-market trading after the company reported the submission of New Drug Application for vibegron for the treatment of overactive bladder.
  • Innate Pharma S.A. (NASDAQ: IPHA) shares rose 5.4% to $6.78 in pre-market trading.
  • Oncolytics Biotech Inc. (NASDAQ: ONCY) rose 5.4% to $4.08 in pre-market trading after jumping 36.27% on Monday.
  • MEI Pharma Inc (NASDAQ: MEIP) rose 4.3% to $2.45 in pre-market trading after New Enterprise Associates 16 reported a 9.8% active stake in the company.
  • Pyxus International, Inc. (NYSE: PYX) shares rose 4% to $9.04 in pre-market trading after climbing 8.48% on Monday.
  • Coeur Mining, Inc. (NYSE: CDE) rose 3.1% to $8.30 in pre-market trading.
  • SINA Corporation (NASDAQ: SINA) rose 2.2% to $38.01 in pre-market trading after announcing a $500 million share repurchase program.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Core Laboratories N.V. (NYSE: CLB) fell 9.4% to $43.00 in pre-market trading after the company lowered its Q4 guidance and issued weak forecast for the first quarter. The company also announced plans to cut its quarterly dividend.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) fell 4.3% to $5.86 in pre-market trading after rising 17.47% on Monday.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares fell 3.3% to $3.23 in pre-market trading.
  • Rite Aid Corporation (NYSE: RAD) fell 2.7% to $15.56 in pre-market trading after declining 21.23% on Monday.